Medigene to present first pre-clinical data for MDG1015
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology
Globe Newswire16-03-2023, 16:04
EMOV becomes largest shareholder in UK-listed Nostrum Oil & 15-03-2023, 16:49